Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
682 studies found for:    "Migraine Disorders"
Show Display Options
Rank Status Study
21 Completed Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
Conditions: Migraine;   Classic Migraine;   Common Migraine
Intervention: Drug: topiramate; almotriptan malate
22 Completed Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
Conditions: Probable Migraine;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Ketorolac Tromethamine;   Drug: Metoclopramide
23 Terminated PRIMA PFO Migraine Trial
Conditions: Migraine;   Migraine With Aura;   Patent Foramen Ovale;   PFO
Intervention: Device: AMPLATZER® PFO Occluder Device
24 Completed Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Laxymig ER (drug)
25 Recruiting Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial
Condition: Migraine Disorders
Interventions: Drug: Metoclopramide 10 mg;   Drug: Placebo;   Drug: Fentanyl
26 Completed Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Dronabinol MDI
27 Completed IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice
Conditions: Headache Disorders, Primary;   Migraine With Aura;   Migraine Without Aura;   Tension-Type Headache
28 Completed A Pilot Study of Migraine and Appetite Behaviour in Children
Conditions: Migraine Disorders;   Obesity
29 Completed
Has Results
Migraine Study in Adolescent Patients
Condition: Migraine Disorders
Interventions: Drug: Sumatriptan and Naproxen Sodium;   Drug: Placebo
30 Completed Migraine and Body Composition
Conditions: Migraine With and Without Aura;   Chronic Migraine;   Healthy Controls
31 Recruiting Nutrition for Migraine Prevention
Condition: Migraine Disorders
Intervention: Other: Diet
32 Completed Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Maxalt 10mg MLT plus Caffeine 75mg;   Drug: Maxalt 10mg MLT plus Placebo;   Drug: Placebo + Placebo
33 Recruiting tDCS for the Treatment of Migraine
Condition: Migraine Disorders
Intervention: Device: tdcs
34 Completed TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
Conditions: Migraine With or Without Aura;   Migraine Disorders
Interventions: Drug: Combination Product (sumatriptan succinate / naproxen sodium);   Drug: RELPAX(eletriptan) 40mg Tablet
35 Recruiting Optimized tDCS for the Treatment of Migraine
Condition: Migraine Disorders
Interventions: Procedure: anodal tDCS on M1;   Procedure: cathodal tDCS on M1;   Procedure: anodal tDCS on V1;   Procedure: cathodal tDCS on V1;   Procedure: anodal tDCS on M1 and cathodal on V1;   Procedure: cathodal tDCS on M1 and anodal on V1;   Procedure: sham tDCS
36 Completed Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
Condition: Migraine Disorders
Interventions: Drug: Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap);   Drug: Triptan monotherapy
37 Withdrawn Aspirin Resistance in Women With Migraine
Conditions: Episodic Migraine;   Chronic Migraine
Interventions: Drug: Aspirin (acetylsalicylic acid);   Drug: Placebo
38 Completed Botox Injection in Treatment of Chronic Migraine
Condition: Migraine Disorders
Intervention: Drug: Botulinum Toxin Type A
39 Active, not recruiting A Multicenter Assessment of ALD403 in Chronic Migraine
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Placebo
40 Completed Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
Condition: Migraine Disorders
Interventions: Drug: Non-steroidal anti-inflammatory drug (NSAID);   Drug: Triptan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years